Highlight,-Analysts give Abbott Laboratories a "Moderate Buy" rating with a target price of $130.07.,-Recent dividend ...
In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Dexcom (DXCM – Research Report), with a price ...
Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis • The investigational transcatheter aortic valve implantation (TAVI) system will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback